Matexcel PDLGA Granule BIOD-010

Description
Storage: Store at 4°C. Application: Drug release: PDLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PDLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability and bioavailability, commonly used in drug sustained release systems; Tissue engineering: PDLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields; Medical devices: PDLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, detachable surgical sutures, etc.; Product overview: This product is a granular copolymer of DL-lactide and glycolide (PDLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations. Viscosity: DL-lactide and glycolide copolymer, molar ratio 50/50: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 50/50: 1.0 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.7 dl/g
Datasheet
Description
Storage: Store at 4°C. Application: Drug release: PDLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PDLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability and bioavailability, commonly used in drug sustained release systems; Tissue engineering: PDLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields; Medical devices: PDLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, detachable surgical sutures, etc.; Product overview: This product is a granular copolymer of DL-lactide and glycolide (PDLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations. Viscosity: DL-lactide and glycolide copolymer, molar ratio 50/50: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 50/50: 1.0 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.7 dl/g
Datasheet

Suppliers

Company
Product
Description
Supplier Links
PDLGA Granule - BIOD-010 - Matexcel
Shirley, NY, United States
PDLGA Granule
BIOD-010
PDLGA Granule BIOD-010
Storage: Store at 4°C. Application: Drug release: PDLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PDLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability and bioavailability, commonly used in drug sustained release systems; Tissue engineering: PDLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields; Medical devices: PDLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, detachable surgical sutures, etc.; Product overview: This product is a granular copolymer of DL-lactide and glycolide (PDLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations. Viscosity: DL-lactide and glycolide copolymer, molar ratio 50/50: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 50/50: 1.0 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.7 dl/g

Storage: Store at 4°C.

Application:

Drug release: PDLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PDLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability and bioavailability, commonly used in drug sustained release systems;
Tissue engineering: PDLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields;
Medical devices: PDLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, detachable surgical sutures, etc.;

Product overview: This product is a granular copolymer of DL-lactide and glycolide (PDLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations.

Viscosity:

DL-lactide and glycolide copolymer, molar ratio 50/50: 0.2 dl/g
DL-lactide and glycolide copolymer, molar ratio 50/50: 1.0 dl/g
DL-lactide and glycolide copolymer, molar ratio 75/25: 0.2 dl/g
DL-lactide and glycolide copolymer, molar ratio 75/25: 0.7 dl/g

Supplier's Site Datasheet

Technical Specifications

  Matexcel
Product Category Biological Materials
Product Number BIOD-010
Product Name PDLGA Granule
Unlock Full Specs
to access all available technical data

Similar Products